Fundamental XR expands access to immersive training with web-enabled platform

Tern plc

Fundamental XR has launched Immersive Web, a platform designed to extend immersive training beyond headset-only environments and into the browser.

The company’s core proposition has centred on delivering high-fidelity, hands-on training through virtual environments. While immersive hardware enables realistic and repeatable skill development, full deployment can require logistical planning, capital investment and on-site coordination. Immersive Web introduces a browser-based layer that allows elements of training to be accessed without dedicated equipment, widening the potential user base and reducing friction at the point of entry.

This approach alters the economics of implementation. Organisations can begin engagement through standard web browsers, enabling learners to complete preparatory modules, theoretical instruction and guided walkthroughs before progressing to fully immersive simulations. By separating foundational learning from advanced practical application, the platform supports a more staged investment model.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Fundamental XR builds case for wider surgical simulation adoption

Fundamental XR is expanding the role of virtual simulation in surgical training as hospitals integrate the technology into structured education programmes.

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Search